Westhampton Capital, LLC Bristol Myers Squibb CO Transaction History

Westhampton Capital, LLC

$196 Million
Q3 2024

A detailed history of Westhampton Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Westhampton Capital, LLC holds 27,217 shares of BMY stock, worth $1.5 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

27,217

Previous 15,517 75.4%

Holding current value

$1.5 Million

Previous $644,000 118.63%

% of portfolio

0.72%

Previous 0.35%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $464,021 - $605,475	11,700 Added 75.4%	27,217 $1.41 Million
Q2 2024 Jul 19, 2024	BUY	$40.25 - $52.99 $235,462 - $309,991	5,850 Added 60.52%	15,517 $644,000
Q1 2024 Apr 18, 2024	BUY	$47.98 - $54.4 $179,685 - $203,728	3,745 Added 63.24%	9,667 $524,000
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $388,809 - $463,957	-8,020 Reduced 57.52%	5,922 $303,000
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $4,793 - $5,676	-70 Reduced 0.5%	13,942 $0
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $39 - $23,052	-300 Reduced 2.1%	14,012 $996,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $12,296 - $14,744	-200 Reduced 1.38%	14,312 $1.05 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $153,842 - $180,206	-2,600 Reduced 15.19%	14,512 $859,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 0.58%	17,112 $1.14 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $59,340 - $66,740	1,000 Added 6.17%	17,212 $1.09 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $11,548 - $13,086	-200 Reduced 1.22%	16,212 $1.01 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $7,465 - $8,273	-130 Reduced 0.79%	16,412 $989,000
Q2 2020 Jul 17, 2020	BUY	$54.82 - $64.09 $16,446 - $19,227	300 Added 1.85%	16,542 $973,000
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $10,904 - $15,846	-235 Reduced 1.43%	16,242 $905,000
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $376,456 - $491,053	7,650 Added 86.67%	16,477 $1.06 Million
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $33,360 - $39,553	780 Added 9.69%	8,827 $448,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $359,057 - $397,038	8,047 New	8,047 $365,000

Others Institutions Holding BMY

# of Institutions

2,457

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $118B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westhampton Capital, LLC with notifications on news.

Account

Westhampton Capital, LLC Bristol Myers Squibb CO Transaction History